ArticleActa oncologica (Stockholm, Sweden)2025

Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses.

Christian Rønn Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.